Taylored Biotherapeutics

Taylored Biotherapeutics is a Calgary-based biotechnology company specializing in the development of microbiome-derived therapeutics, specifically "psychobiotics," to treat mental health disorders. Founded by Dr. Valerie Taylor, the company leverages a proprietary platform that combines clinical neuroscience, gut microbiome research, and machine learning to engineer live bacterial strains. Their lead programs target bipolar disorder and depression, aiming to provide safe, side-effect-free alternatives to traditional psychiatric medications. The company utilizes data from human fecal microbiota transplant (FMT) studies to inform its precision medicine approach. Taylored Biotherapeutics has established key partnerships with Netramark for AI-driven drug development and the University of Calgary's Innovate Calgary.